The efficacy and safety of anti-PD-1/PD-L1 antibodies combined with chemotherapy or CTLA4 antibody as a first-line treatment for advanced lung cancer-Reference-Cited by-同舟云学术

The efficacy and safety of anti-PD-1/PD-L1 antibodies combined with chemotherapy or CTLA4 antibody as a first-line treatment for advanced lung cancer

Published:2018-01-25 Issue:11 Volume:142 Page:2344-2354
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Xu Xiaoling¹²,Huang Zhiyu²,Zheng Lei¹,Fan Yun¹²^ORCID

Affiliation:

1. Key laboratory on Diagnosis and Treatment Technology on Thoracic Cancer; Zhejiang Cancer Hospital (Zhejiang Cancer Research Institute); Hangzhou Zhejiang Province 310022 China

2. Department of Medical Oncology; Zhejiang Cancer Hospital, 38 Guangji Road; Hangzhou City China

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference51 articles.

1. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012;Ferlay;Int J Cancer,2015

2. Cancer statistics in China, 2015;Chen;CA Cancer J Clin,2016

3. Global cancer statistics;Jemal;CA Cancer J Clin,2011

4. Estimation and projection of the national profile of cancer mortality in China: 1991-2005;Yang;Br J Cancer,2004

5. Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC);Barr Kumarakulasinghe;Respirology,2015

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic strategies targeting CD47-SIRPα signaling pathway in gastrointestinal cancers treatment;Journal of Pharmaceutical Analysis;2024-09

2. Efficacy and safety of first-line immunotherapy plus chemotherapy in treating patients with extensive-stage small cell lung cancer: a Bayesian network meta-analysis;Frontiers in Immunology;2023-06-26

3. FCRL4 Memory B Cells Interact with Tissue-Resident CD8 T Cells to Participate in Anti-Tumor Immunity in Nasopharyngeal Carcinoma;2023

4. Treatment-related adverse events of PD-1/PD-L1 inhibitors combined with CTLA-4 inhibitors in clinical trials: a meta-analysis;Artificial Cells, Nanomedicine, and Biotechnology;2022-10-10

5. The Roles and Mechanisms of TRAT1 in the Progression of Non-Small Cell Lung Cancer;Current Medical Science;2022-10-03